Toggle navigation
Home
Search
Services
Blog
Contact
About
Synthesis of Cochleamycins - Novel Antitumor Antibiotics
Cumming, Jared N.
Stanford University, Stanford, CA, United States
Search grants from Jared Cumming
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Electrophysiology of Neonatal and Adult Heart
Family Conflict and Decision Making for Advanced Cancer
Dissection of Ras-Dependent Pathways in S Cerevisiae
Differentiation of Sexual Behavior
Modulation of Acetylcholine Release in Airway Disease
Recently added grants:
Phage extracellular polysaccharide depolymerases to combat Pseudomonas aeruginosa biofilms
Cholinergic contribution to pupil-linked arousal
The effects of BTNL2 on experimental autoimmune encephalomyelitis
Transitions in Care for Older Nursing Home Residents with Dementia from Entry to Death: a retrospective cohort study, 2014-2019
Patient-Specific Strategies for Capsular Repair Following Shoulder Dislocations
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA075624-02
Application #
2824497
Study Section
Special Emphasis Panel (ZRG3-MCHA (01))
Program Officer
Lohrey, Nancy
Project Start
1998-10-27
Project End
Budget Start
1998-10-27
Budget End
1999-10-26
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1998
F32 CA
Synthesis of Cochleamycins - Novel Antitumor Antibiotics
Cumming, Jared N. / Stanford University
NIH 1997
F32 CA
Synthesis of Cochleamycins - Novel Antitumor Antibiotics
Cumming, Jared N. / Stanford University
Comments
Be the first to comment on Jared Cumming's grant